Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: well-documented, non-GLP but guideline-conform study report

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1990
Report date:
1990

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
GLP compliance:
no
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
Chromium trioleate
EC Number:
244-256-3
EC Name:
Chromium trioleate
Cas Number:
21178-63-2
Molecular formula:
C18 H34 O2 .1/3 Cr
IUPAC Name:
chromium(3+) tris((9Z)-octadec-9-enoate)
Details on test material:
Name of the test substance used in the study report: Chrom(III)-Oleat

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
5 animals per cage (type: stainless steel wire mesh with no bedding); animal identification via cage cards. The rats were housed in fully air-conditioned rooms with a temperature ranging from 20 - 24°C and a relative humidity of 30 - 70%. The day/night rhythm was 12 h dark and 12 h light. A standardized laboratory diet as well as tap water were available ad libitum. Young adult rats of a comparable weight were used.

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
olive oil
Details on oral exposure:
The test substance was insoluble in water. The test substance was administered as a solution.
Doses:
2000 mg/kg
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: several times on the day of administration (at least once each working day)
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Mortality:
none
Clinical signs:
other: none
Gross pathology:
No pathologic findings noted.

Applicant's summary and conclusion